William Sandborn
Gründer bei Shoreline Biosciences, Inc.
Vermögen: 294 687 $ am 30.04.2024
Aktive Positionen von William Sandborn
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of California San Diego | Corporate Officer/Principal | 01.01.2011 | - |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - | - |
Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Gründer | - | - | |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Berater | - | - |
Karriereverlauf von William Sandborn
Ehemalige bekannte Positionen von William Sandborn
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VENTYX BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.05.2022 | 22.11.2023 |
Präsident | 09.05.2022 | 22.11.2023 | |
PROMETHEUS BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | - | 04.02.2021 |
Ausbildung von William Sandborn
Loma Linda University | Doctorate Degree |
Southern University College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Deutschland | 2 |
Malaysia | 2 |
Operativ
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VENTYX BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Finance |
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Health Technology |
- Börse
- Insiders
- William Sandborn
- Erfahrung